“An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers”, Arch Clin Psychiatry (former: Rev Psiq Clin), vol. 47, no. 2, pp. 51–54, Apr. 2020, doi: 10.1590/0101-60830000000231.